Market Overview:
The global Valsartan drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension, heart failure, and heart attack across the globe. In addition, rising awareness about the benefits of using Valsartan drugs is also contributing to the growth of this market. The global Valsartan drug market can be segmented on the basis of type into 40 mg tablets, 80 mg tablets, 160 mg tablets, and 320 mg tablets. The 80 mg tablet segment is expected to account for a major share in terms of revenue in this market during the forecast period from 2018 to 2030. This segment is anticipated to grow at a CAGR of 5% during this period owing to its high demand among patients suffering from hypertension and heart failure. On the basis of application,the global Valsartan drugmarket can be divided into hypertension, heart failure, and heart attack segments.
Product Definition:
Valsartan is a drug used to treat high blood pressure and congestive heart failure. It is also used to prevent heart attacks and strokes in people with risk factors for those conditions.
40 mg Tablets:
40 mg Tablets is used for the treatment of heart failure with New York Heart Association (NYHA) class III and IV symptoms. It works by improving the ability of the heart to pump blood around the body. This drug also reduces swelling in your chest due to inflammation and helps improve breathing.
80 mg Tablets:
80 mg Tablets is used for the treatment of hypertension and to lower the risk of stroke and heart attack. It also helps in reducing kidney stones, angina (chest pain), fluid retention, swelling due to arthritis, migraine headaches as well as improves oxygen supply to the tissues in case of injuries or surgeries.
Application Insights:
On the basis of application, the global valsartan drug market has been segmented into hypertension, heart failure, and heart attack. Hypertension was estimated to be the largest application segment in 2017 owing to high prevalence of high blood pressure among adults. Valsartan is widely used for treating hypertension as it reduces blood pressure by lowering down vascular resistance and increasing renal excretion.
The European Medicines Agency approved valsartan tablets 40 mg, 80 mg and 160 mg for use in patients with systolic hypertension (blood pressure greater than or equal to 140 mmHg) or diastolic hypertension (blood pressure less than 90 mmHg) on July 19th 2018. This approval marks a step forward in addressing unmet medical needs related to treatment of essential Hypertension (EH).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high consumer awareness is responsible for its large share. Furthermore, the region has one of the highest per capita income and health care spending in the world which further increases its revenue share.
Asia Pacific is expected to be one of fastest growing regions during the forecast period owing to increasing disposable income levels, rising population and prevalence of hypertension among all age groups especially among men. In addition, China accounts for a major share due to low manufacturing cost as well as easy availability off patent drugs at cheaper prices compared to branded ones thus making it an attractive market for global players keen on entering into this lucrative industry space with affordable products that provide better results than their counterparts from other countries.
Growth Factors:
- Increasing prevalence of hypertension and other cardiac disorders: The global Valsartan drug market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing prevalence of hypertension and other cardiac disorders.
- Rising geriatric population: The growth in the geriatric population is expected to fuel the demand for Valsartan drugs, as this population is more susceptible to heart diseases.
- Technological advancements in drug delivery systems: Drug delivery systems are witnessing rapid advancements, which is likely to boost the uptake of Valsartan drugs in coming years. This would provide better patient compliance and convenience, thus propelling market growth further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Valsartan Drug Market Research Report
By Type
40 mg Tablets, 80 mg Tablets, 160 mg Tablets, 320 mg Tablets
By Application
Hypertension, Heart Failure, Heart Attack
By Companies
Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals, HETERO, Torrent Pharmaceuticals, Huaren Pharmaceutical, Jubilant Pharma, Amneal Pharmaceuticals, Zhejiang Huahai Pharmaceutical, Square Pharmaceuticals, Unichem Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Valsartan Drug Market Report Segments:
The global Valsartan Drug market is segmented on the basis of:
Types
40 mg Tablets, 80 mg Tablets, 160 mg Tablets, 320 mg Tablets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypertension, Heart Failure, Heart Attack
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Sun Pharmaceutical
- Teva
- Mylan
- Alembic Pharmaceuticals
- Lupin
- Aurobindo Pharma
- Macleods Pharmaceuticals
- HETERO
- Torrent Pharmaceuticals
- Huaren Pharmaceutical
- Jubilant Pharma
- Amneal Pharmaceuticals
- Zhejiang Huahai Pharmaceutical
- Square Pharmaceuticals
- Unichem Laboratories
Highlights of The Valsartan Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 40 mg Tablets
- 80 mg Tablets
- 160 mg Tablets
- 320 mg Tablets
- By Application:
- Hypertension
- Heart Failure
- Heart Attack
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Valsartan Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Valsartan is a medication used to lower blood pressure. It is also known by the trade name Diovan.
Some of the major companies in the valsartan drug market are Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals, HETERO, Torrent Pharmaceuticals, Huaren Pharmaceutical, Jubilant Pharma, Amneal Pharmaceuticals, Zhejiang Huahai Pharmaceutical, Square Pharmaceuticals, Unichem Laboratories.
The valsartan drug market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Valsartan Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Valsartan Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Valsartan Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Valsartan Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Valsartan Drug Market Size & Forecast, 2018-2028
4.5.1 Valsartan Drug Market Size and Y-o-Y Growth
4.5.2 Valsartan Drug Market Absolute $ Opportunity
Chapter 5 Global Valsartan Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Valsartan Drug Market Size Forecast by Type
5.2.1 40 mg Tablets
5.2.2 80 mg Tablets
5.2.3 160 mg Tablets
5.2.4 320 mg Tablets
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Valsartan Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Valsartan Drug Market Size Forecast by Applications
6.2.1 Hypertension
6.2.2 Heart Failure
6.2.3 Heart Attack
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Valsartan Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Valsartan Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Valsartan Drug Analysis and Forecast
9.1 Introduction
9.2 North America Valsartan Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Valsartan Drug Market Size Forecast by Type
9.6.1 40 mg Tablets
9.6.2 80 mg Tablets
9.6.3 160 mg Tablets
9.6.4 320 mg Tablets
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Valsartan Drug Market Size Forecast by Applications
9.10.1 Hypertension
9.10.2 Heart Failure
9.10.3 Heart Attack
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Valsartan Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Valsartan Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Valsartan Drug Market Size Forecast by Type
10.6.1 40 mg Tablets
10.6.2 80 mg Tablets
10.6.3 160 mg Tablets
10.6.4 320 mg Tablets
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Valsartan Drug Market Size Forecast by Applications
10.10.1 Hypertension
10.10.2 Heart Failure
10.10.3 Heart Attack
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Valsartan Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Valsartan Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Valsartan Drug Market Size Forecast by Type
11.6.1 40 mg Tablets
11.6.2 80 mg Tablets
11.6.3 160 mg Tablets
11.6.4 320 mg Tablets
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Valsartan Drug Market Size Forecast by Applications
11.10.1 Hypertension
11.10.2 Heart Failure
11.10.3 Heart Attack
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Valsartan Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Valsartan Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Valsartan Drug Market Size Forecast by Type
12.6.1 40 mg Tablets
12.6.2 80 mg Tablets
12.6.3 160 mg Tablets
12.6.4 320 mg Tablets
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Valsartan Drug Market Size Forecast by Applications
12.10.1 Hypertension
12.10.2 Heart Failure
12.10.3 Heart Attack
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Valsartan Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Valsartan Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Valsartan Drug Market Size Forecast by Type
13.6.1 40 mg Tablets
13.6.2 80 mg Tablets
13.6.3 160 mg Tablets
13.6.4 320 mg Tablets
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Valsartan Drug Market Size Forecast by Applications
13.10.1 Hypertension
13.10.2 Heart Failure
13.10.3 Heart Attack
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Valsartan Drug Market: Competitive Dashboard
14.2 Global Valsartan Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Sun Pharmaceutical
14.3.3 Teva
14.3.4 Mylan
14.3.5 Alembic Pharmaceuticals
14.3.6 Lupin
14.3.7 Aurobindo Pharma
14.3.8 Macleods Pharmaceuticals
14.3.9 HETERO
14.3.10 Torrent Pharmaceuticals
14.3.11 Huaren Pharmaceutical
14.3.12 Jubilant Pharma
14.3.13 Amneal Pharmaceuticals
14.3.14 Zhejiang Huahai Pharmaceutical
14.3.15 Square Pharmaceuticals
14.3.16 Unichem Laboratories
